Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia

References

• Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443-56
   PubMed Web of Science ®Google Scholar
• Auten RL, Notter RH, Kendig JW, et al. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991;87:101-7
   PubMed Web of Science ®Google Scholar
• Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9
   PubMedGoogle Scholar
• Greenough A, Alexander J, Burgess S, et al. Preschool healthcare utilisation related to home oxygen status. Arch Dis Child Fetal Neonatal Ed 2006;91:F337-41
   PubMed Web of Science ®Google Scholar
• Greenough A, Cox S, Alexander J, et al. Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child 2001;85:463-8
   PubMed Web of Science ®Google Scholar
• Gross SJ, Iannuzzi DM, Kveselis DA, Anbar RD. Effect of preterm birth on pulmonary function at school age: a prospective controlled study. J Pediatr 1998;133:188-92
   PubMed Web of Science ®Google Scholar
• Vrijlandt EJ, Gerritsen J, Boezen HM, Duiverman EJ. Gender differences in respiratory symptoms in 19-year-old adults born preterm. Respir Res 2005;6:117
   PubMed Web of Science ®Google Scholar
• Friedrich L, Pitrez PM, Stein RT, et al. Growth rate of lung function in healthy preterm infants. Am J Respir Crit Care Med 2007;176:1269-73
   PubMed Web of Science ®Google Scholar
• Gough A, Spence D, Linden M, et al. General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review. Chest 2012;141:1554-67
   PubMed Web of Science ®Google Scholar
• Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-3
   PubMed Web of Science ®Google Scholar
• Coalson JJ. Pathology of bronchopulmonary dysplasia. Seminar Perinatol 2006;30:179-84
   PubMed Web of Science ®Google Scholar
• Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000;279:L600-7
   PubMed Web of Science ®Google Scholar
• Hislop AA, Haworth SG. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990;9:152-61
   PubMed Web of Science ®Google Scholar
• Khemani E, McElhinney DB, Rhein L, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007;120:1260-9
   PubMed Web of Science ®Google Scholar
• del Cerro MJ, Rotes A, Carton A, et al. Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes. Pediatr Pulmonol 2014;49:49-59
   PubMed Web of Science ®Google Scholar
• Bhat R, Salas AA, Foster C, et al. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 2012;129:e682-9
   PubMed Web of Science ®Google Scholar
• An HS, Bae EJ, Kim GB, et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 2010;40:131-6
   PubMedGoogle Scholar
• Mourani PM, Dunbar Ivy D, Rosenberg AA, et al. Left ventricular diastolic dysfunction in bronchopulmonary dysplasia. J Pediatr 2008;152:291-3
   PubMed Web of Science ®Google Scholar
• Chinnaiyan KM, Alexander D, Maddens FA, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterisation study. Circulation 2000;153:189-200
   Google Scholar
• Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opinion Pediatr 2013;25:329-37
   PubMed Web of Science ®Google Scholar
• Haworth SG. The management of pulmonary hypertension in children. Arch Dis Dhild 2008;93:620-5
   PubMed Web of Science ®Google Scholar
• Fitzgerald D, Evans N, Van Asperen P, Henderson-Smart D. Subclinical persisting pulmonary hypertension in chronic neonatal lung disease. Arch Dis Child Fetal Neonatal Ed 1994;70:F118-22
   PubMed Web of Science ®Google Scholar
• Blanchard DG, Malouf PJ, Gurudevan SV, et al. Utility of right ventricular Tei index in the noninvasive evaluation of chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy. JACC Cardiovas Imaging 2009;2:143-9
   PubMed Web of Science ®Google Scholar
• Ishii M, Eto G, Tei C, et al. Quantitation of the global right ventricular function in children with normal heart and congenital heart disease: a right ventricular myocardial performance index. Pediatr Cardiol 2000;21:416-21
   PubMed Web of Science ®Google Scholar
• Czernik C, Rhode S, Metze B, et al. Persistently elevated right ventricular index of myocardial performance in preterm infants with incipient bronchopulmonary dysplasia. PLoS One 2012;7:e38352
   PubMedGoogle Scholar
• Mourani PM, Sontag MK, Younoszai A, et al. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008;121:317-25
   PubMed Web of Science ®Google Scholar
• Kreitner K-F. Noninvasive Imaging of Pulmonary Hypertension. Seminar Respir Crit Care Med 2014;35:099-111
   PubMed Web of Science ®Google Scholar
• Roeleveld RJ, Marcus JT, Boonstra A, et al. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 2005;22:67-72
   PubMed Web of Science ®Google Scholar
• Sanz J, Kuschnir P, Rius T, et al. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 2007;243:70-9
   PubMed Web of Science ®Google Scholar
• Nogami M, Ohno Y, Koyama H, et al. Utility of phase contrast MR imaging for assessment of pulmonary flow and pressure estimation in patients with pulmonary hypertension: comparison with right heart catheterisation and echocardiography. J Magn Reson Imaging 2009;30:973-80
   PubMed Web of Science ®Google Scholar
• Dellegrottaglie S, Sanz J, Poon M, et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 2007;243:63-9
   PubMed Web of Science ®Google Scholar
• Jean AT, Robert JF, Stephanie LM, et al. Imaging Within The Neonatal Intensive Care Unit. B55 intensive care, pulmonary hypertension, and transplantation topics. American Thoracic Society International Conference Abstracts: American Thoracic Society, San Diego; 2014. A3251-A
   Google Scholar
• Vijibrief DC, Benders MJ, Kemperman H, et al. B-type natriuretic peptide and rebound during treatment for persistent pulmonary hypertension. J Pediatr 2012;160:111-15
   PubMed Web of Science ®Google Scholar
• Nir A, Lindinger A, Rauh M, et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009;30:3-8
   PubMed Web of Science ®Google Scholar
• Warwick G, Thomas PS, Yates DH. Biomarkers in pulmonary hypertension. Eur Respir J 2008;32:503-12
   PubMed Web of Science ®Google Scholar
• Mourani PM, Ivy DD, Gao D, Abman SH. Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2004;170:1006-13
   PubMed Web of Science ®Google Scholar
• Ambalavanan N, Mourani P. Pulmonary hypertension in bronchopulmonary dysplasia. Birth defects research Part A. Clin Molecular Teratol 2014;100:240-6
   PubMed Web of Science ®Google Scholar
• Balfour-Lynn IM, Field DJ, Gringras P, et al. BTS guidelines for home oxygen in children. Thorax 2009;64:1-26
   PubMed Web of Science ®Google Scholar
• Banks B, Seri I, Ischiropoulos H, et al. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics 1999;103:610
   PubMed Web of Science ®Google Scholar
• Wardle AJ, Wardle R, Luyt K, Tulloh R. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia. Arch Dis Child 2013;98:613-17
   PubMed Web of Science ®Google Scholar
• Steinhorn RH, Kinsella JP, Pierce C, et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 2009;155:841-7
   PubMed Web of Science ®Google Scholar
• Maxted AP, Davies P. Oral sildenafil as a rescue therapy in presumed acute pulmonary hypertensive crisis. Pediatrics 2013;131:e626-8
   PubMed Web of Science ®Google Scholar
• Caputo S, Furcolo G, Rabuano R, et al. Severe pulmonary arterial hypertension in a very premature baby with bronchopulmonary dysplasia: normalization with long-term sildenafil. J Cardiovasc Med 2010;11:704-6
   Google Scholar
• Ellis H KI, Cheung KL, Siu KL, et al. Oral sildenafil for treatment of severe pulmonary hypertension in an infant. Biol Neonate 2005;88:109-12
   PubMedGoogle Scholar
• Nyp M, Sandritter T, Poppinga N, et al. Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits? J Perinat 2012;32:64-9
   PubMed Web of Science ®Google Scholar
• Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 2009;154:379-84
   PubMed Web of Science ®Google Scholar
• Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation 2012;125:324-34
   PubMed Web of Science ®Google Scholar
• Shah PS, Ohlsson A. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev 2011;8:CD005494
   PubMed Web of Science ®Google Scholar
• Yung D, Widlitz AC, Rosenzweig EB, et al. Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation 2004;110:660-5
   PubMed Web of Science ®Google Scholar
• Gurakan B, Kayiran P, Ozturk N, et al. Therapeutic combination of sildenafil and iloprost in a preterm neonate with pulmonary hypertension. Pediatr Pulmonol 2011;46:617-20
   PubMed Web of Science ®Google Scholar
• Zaidi AN, Dettorre MD, Ceneviva GD, Thomas NJ. Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease. Pediatr Pulmonol 2005;40:265-9
   PubMed Web of Science ®Google Scholar
• Ivy DD, Doran AK, Smith KJ, et al. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am College Cardiol 2008;51:161-9
   PubMed Web of Science ®Google Scholar
• Ivy DD, Claussen L, Doran A. Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil. Am J Cardiol 2007;99:696-8
   PubMed Web of Science ®Google Scholar
• Kelly LK, Porta NF, Goodman DM, et al. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002;141:830-2
   PubMed Web of Science ®Google Scholar
• Steinhorn RH. Diagnosis and treatment of pulmonary hypertension in infancy. Early Hum Dev 2013;89:865-74
   PubMed Web of Science ®Google Scholar
• Thelitz S, Oishi P, Sanchez LS, et al. Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs. Pediatr Crit Care Med 2004;5:234-9
   PubMedGoogle Scholar
• McNamara PJ, Laique F, Muang-In S, Whyte HE. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006;21:217-22
   PubMed Web of Science ®Google Scholar
• Bassler D, Choong K, McNamara P, Kirpalani H. Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 2006;89:1-5
   PubMedGoogle Scholar
• Bassler D, Kreutzer K, McNamara P, Kirpalani H. Milrinone for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev 2010;11:CD007802
   PubMedGoogle Scholar
• Abman SH. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. Ann Rev Med 2009;60:13-23
   PubMed Web of Science ®Google Scholar
• Wagenaar G, de Visser Y, Laghmani EH, Walther F. Ambrisentan attenuates lung and heart injury in a rat model of bronchopulmonary dysplasia. Eur Respir J 2011;38:Suppl 55
   Google Scholar
• Baker CD, Abman SH, Mourani PM. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Pediatr Allergy Immunol Pulmonol 2014;27:8-16
   PubMed Web of Science ®Google Scholar
• Ivy DD, Rosenzweig EB, Lemarié J-C, et al. Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings. Am J Cardiol 2010;106:1332-8
   PubMed Web of Science ®Google Scholar
• Krishnan U, Krishnan S, Gewitz M. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies. Pediatr Cardiol 2008;29:1082-6
   PubMed Web of Science ®Google Scholar
• Hislop AA, Moledina S, Foster H, et al. Long term efficacy of bosentan in treatment of pulmonary arterial hypertension in children. Eur Respir J 2011;38:70-7
   PubMed Web of Science ®Google Scholar
• New Z, Fitzgerald DA, Massie RJ, et al. Infants with chronic neonatal lung disease: recommendations for the use of home oxygen therapy. Med J Australia 2008;189:578-82
   PubMed Web of Science ®Google Scholar
• Balfour-Lynn IM, Field DJ, Gringras P, et al. BTS guidelines for home oxygen in children. Thorax 2009;64:1-26
   PubMed Web of Science ®Google Scholar
• Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterisation. Anesth Analg 2007;104:521-7
   PubMed Web of Science ®Google Scholar
• Joshi S, Wilson DG, Kotecha S, et al. Cardiovascular function in children who had chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 2014;99(5):F373-9
   PubMed Web of Science ®Google Scholar
• Zivanovic S, Pushparajah K, Lo J, et al. P09 Pulmonary artery pressures in school age children born very prematurely. Arch Dis Child 2014;99(Suppl 1):A4
   Google Scholar
• Lewandowski AJ, Augustine D, Lamata P, et al. Preterm heart in adult life: cardiovascular magnetic resonance reveals distinct differences in left ventricular mass, geometry, and function. Circulation 2013;127:197-206
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New Engl J Med 1990;322:1561-6
   PubMed Web of Science ®Google Scholar
• de Simone G, Verdecchia P, Pede S, et al. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension 2002;40:470-6
   PubMed Web of Science ®Google Scholar
• Adatia I, Haworth SG, Wegner M, et al. Clinical trials in neonates and children: report of the pulmonary hypertension academic research consortium pediatric advisory committee. Pulm Circ 2013;3:252-66
   Google Scholar
• Shimoda LA, Semenza GL. HIF and the lung. Am J Respir Crit Care Med 2011;183:152-6
   PubMed Web of Science ®Google Scholar
• Grover TR, Asikainen TM, Kinsella JP, et al. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs. Am J Physiol Lung Cell Mol Physiol 2007;292:L1345-51
   PubMed Web of Science ®Google Scholar
• Asikainen TM, Chang LY, Coalson JJ, et al. Improved lung growth and function through hypoxia-inducible factor in primate chronic lung disease of prematurity. FASEB 2006;20:1698-700
   PubMed Web of Science ®Google Scholar
• Asikainen TM, Waleh NS, Schneider BK, et al. Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo. Am J Physiol Lung Cell Mol Physiol 2006;291:L588-95
   PubMed Web of Science ®Google Scholar
• Ball MK, Waypa GB, Mungai PT, et al. Regulation of Hypoxia-induced Pulmonary Hypertension by Vascular Smooth Muscle Hypoxia-Inducible Factor-1α. Am J Respir Crit Care Med 2013;189:314-24
   Web of Science ®Google Scholar
• Park H-S, Park J-W, Kim H-J, et al. Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway. Am J Respir Cell Mol Biol 2013;48:105-13
   PubMed Web of Science ®Google Scholar
• Maniscalco WM, Watkins RH, Pryhuber GS, et al. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 2002;282:L811-23
   PubMed Web of Science ®Google Scholar
• Thebaud B, Ladha F, Michelakis ED, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung aniogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005;112:2477-86
   PubMed Web of Science ®Google Scholar
• Kunig Am, Balasubramaniam V, Markham NE, et al. Recombinant human VEGF treatment enhances alveolarisation after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 2005;289:L529-35
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Go D, Krenitsky DL, et al. Genome wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2012;186:349-58
   PubMed Web of Science ®Google Scholar
• Ng GY, Ohlsson A. Cromolyn sodium for the prevention of chronic lung disease in preterm infants. Cochrane Database Syst Rev 2001;2:CD003059
   PubMedGoogle Scholar
• Kumarasamy A, Schmitt I, Nave AH, et al. Lysyl oxidase activity is dysregulated during impaired alveolarisation of mouse and human lungs. Am J Respir Crit Care Med 2009;180:1239-52
   PubMed Web of Science ®Google Scholar
• Witsch TJ, Turowski P, Sakkas E, et al. Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2014;306:L246-59
   PubMed Web of Science ®Google Scholar
• Baker CD, Balasubramaniam V, Mourani PM, et al. Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia. Eur Respir J 2012;40:1516-22
   PubMed Web of Science ®Google Scholar
• Balasubramaniam V, Mervis CF, Maxey AM, et al. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007;292:L1073-84
   PubMed Web of Science ®Google Scholar
• van Haaften T, Byrne R, Bonnet S, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009;180:1131-42
   PubMed Web of Science ®Google Scholar
• Balasubramaniam V, Ryan SL, Seedorf GJ, et al. Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. Am J Physiol Lung Cell Mol Physiol 2010;298:L315-23
   PubMed Web of Science ®Google Scholar